Aberrant Expression of miR-203 and Its Clinical Significance in Gastric and Colorectal Cancers

被引:91
作者
Chiang, Yeunpo [1 ]
Song, Yongxi [1 ]
Wang, Zhenning [1 ]
Chen, Yue [1 ]
Yue, Zhenyu [1 ]
Xu, Huimian [1 ]
Xing, Chengzhong [1 ]
Liu, Zhuangkai [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang 110001, Peoples R China
基金
美国国家科学基金会;
关键词
microRNA; miR-203; Gastric cancer; Colorectal cancer; Clinicopathologic characteristics; TUMOR-SUPPRESSIVE MICRORNAS; CLINICOPATHOLOGICAL SIGNIFICANCE; PROGNOSTIC INDICATOR; PROFILES; SIGNATURE; SIZE;
D O I
10.1007/s11605-010-1367-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background MicroRNAs (miRNAs) are small, non-coding RNAs of endogenous origin, they have been increasingly shown to have aberrant expression in many tumor types. miR-203 has not been comprehensively investigated in gastric and colorectal cancers. Methods Total RNA was extracted from tissues of 212 patients with gastric or colorectal cancer as well as from seven gastric and colorectal cell lines. We determined the expression of miR-203 by real-time PCR and calculated using the 2-(Delta Delta Ct) method. Then, we assessed miR-203 expression and clinicopathologic characteristics. Finally, we studied the effect of miR-203 on cell proliferation in SGC-7901 cells by MTT. Results miR-203 has significantly low expression in colorectal cancer tissues (p < 0.001, paired t test) and cancer cell lines compared to non-tumor counterparts. Moreover, low expression of miR-203 was correlated with tumor size (p = 0.015, non-parametric test) and pT stage (p = 0.005) in colorectal cancer. Although expression of miR-203 was not significant in gastric cancer tissues (p = 0.124), interestingly, miR-203 was correlated with tumor size (p = 0.023), macroscopic type (p = 0.045), and pT stage (p = 0.013). Furthermore, we found miR-203 can inhibit the cell proliferation in SGC-7901 cells. Conclusion miR-203 may be related to the proliferation and invasion of gastric and colorectal cancers.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 36 条
[1]
Tumor size as a simple prognostic indicator for gastric carcinoma [J].
Adachi, Y ;
Oshiro, T ;
Mori, M ;
Maehara, Y ;
Sugimachi, K .
ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (02) :137-140
[2]
Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia [J].
Agirre, Xabier ;
Vilas-Zornoza, Amaia ;
Jimenez-Velasco, Antonio ;
Ignacio Martin-Subero, Jose ;
Cordeu, Lucia ;
Garate, Leire ;
San Jose-Eneriz, Edurne ;
Abizanda, Gloria ;
Rodriguez-Otero, Paula ;
Fortes, Puri ;
Rifon, Jose ;
Bandres, Eva ;
Jose Calasanz, Maria ;
Martin, Vanesa ;
Heiniger, Anabel ;
Torres, Antonio ;
Siebert, Reiner ;
Roman-Gomez, Jose ;
Prosper, Felipe .
CANCER RESEARCH, 2009, 69 (10) :4443-4453
[3]
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets [J].
Baffa, Raffaele ;
Fassan, Matteo ;
Volinia, Stefano ;
O'Hara, Brian ;
Liu, Chang-Gong ;
Palazzo, Juan P. ;
Gardiman, Marina ;
Rugge, Massimo ;
Gomella, Leonard G. ;
Croce, Carlo M. ;
Rosenberg, Anne .
JOURNAL OF PATHOLOGY, 2009, 219 (02) :214-221
[4]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[5]
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression [J].
Bueno, Maria J. ;
Perez de Castro, Ignacio ;
de Cedron, Marta Gomez ;
Santos, Javier ;
Calin, George A. ;
Cigudosa, Juan C. ;
Croce, Carlo M. ;
Fernandez-Piqueras, Jose ;
Malumbres, Marcos .
CANCER CELL, 2008, 13 (06) :496-506
[6]
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[7]
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia [J].
Calin, GA ;
Ferracin, M ;
Cimmino, A ;
Di Leva, G ;
Shimizu, M ;
Wojcik, SE ;
Iorio, MV ;
Visone, R ;
Sever, NI ;
Fabbri, M ;
Iuliano, R ;
Palumbo, T ;
Pichiorri, F ;
Roldo, C ;
Garzon, R ;
Sevignani, C ;
Rassenti, L ;
Alder, H ;
Volinia, S ;
Liu, CG ;
Kipps, TJ ;
Negrini, M ;
Croce, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1793-1801
[8]
MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[9]
Chan SH, 2008, ANTICANCER RES, V28, P907
[10]
MicroRNAs as oncogenes and tumor suppressors [J].
Chen, CZ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1768-1771